Categories
Colon Cancer

Lung Cancer Awareness – A Lung Cancer Patient’s Treatment Journey [Video]

Marilyn C​, stage 4 lung cancer survivor discusses her treatment journey with immunotherapy, how she dealt with the stigma and misinformation associated with the disease, and the importance of lung cancer screenings.#LungCancerAwareness #ImmunotherapyAkron, Ohio resident Marilyn is a wife, mom, aunt, gardener and cancer survivor. Four years ago in November, she received a shocking stage 4 lung cancer diagnosis. Despite only a 25% five-year survival rate, she assured her friends and family that “cancer wasn’t going to be her death sentence.” In hopes of her best chance to live cancer-free, Marilyn’s doctor immediately started her on immunotherapy treatment that has proven to be successful in her cancer journey. In light of Lung Cancer Awareness Month in November, Marilyn is speaking out to share her story and inspire others.

Categories
Colon Cancer

AllyCon 2021: Mental Health During and After Cancer Treatment [Video]

Speaker Sharon Bober shares how to access key elements of mental health during and after cancer treatment, including motivation, self-awareness, and mindful action, as tools for well-being.AllyCon recording from November 15, 2021 at 2:40 pm ET

Categories
Colon Cancer

AllyCon 2021: How to Navigate Clinical Trials for Colorectal Cancer [Video]

Speakers Razelle Kurzrock, MD; John Woerner, Patient Advocate; Tzvia Bader, CEO of Trialjectory; and Manju George, MD, discuss getting the right therapies to the right patients at the right time through clinical trials for colon and rectal cancer.AllyCon recording from November 15, 2021, at 2:40 pm ET

Categories
Colon Cancer

COVID-19 pandemic shifted patient attitudes about colorectal cancer screening [Video]

Kristine Kenning, MD, MS, presented findings from a survey of adults age-eligible for screening at the virtual American College of Surgeons (ACS) Clinical Congress 2021. “The key message from our findings is that barriers to screening have increased during the pandemic, and we have to find a way to work with the community to increase those rates,” said Dr. Kenning, chief general surgery resident at Virginia Commonwealth University (VCU) School of Medicine, Richmond. “Our study found that people are compliant with, and willing to do, home-based fecal occult blood testing. This test provides a very important way for us to increase screening for colorectal cancer.” She and Emily B. Rivet, MD, MBA, FACS explain the findings.

Categories
Colon Cancer

AllyCon 2021 Opening Video: “AllyCon Champions Explorer” [Video]

A short video that opened AllyCon 2021, the Colorectal Cancer Alliance’s national conference, and featured our AllyCon Champions. Our volunteer AllyCon Champions Committee is comprised of conference veterans who are responsible for welcoming and guiding attendees through the event.

Categories
Colon Cancer

Cells, Gene Programs, and Spatially Organized Immune Hubs in MMRd and MMRp Colorectal Cancer [Video]

Speaker: Karin Pelka, Gladstone InstitutesKarin Pelka earned her PhD in innate immunity from the University of Bonn in Germany, where she discovered a key regulatory mechanism that controls the detection of infection- or danger-associated nucleic acids by sensors of the innate immune system. As a postdoctoral fellow at the Broad Institute, she led a cross-disciplinary, multi-institutional single-cell RNA-sequencing and spatial profiling effort on human colorectal cancer. She joined UCSF this fall and is now an assistant investigator at Gladstone Institutes and an assistant professor in the Department of Microbiology and Immunology at UCSF. She is a member of the American Association for Cancer Research, the German Society for Immunology (Deutsche Gesellschaft für Immunologie), and the Society for Immunotherapy of Cancer. Her work aims to understand how immunological processes are regulated in human tissues in order to leverage the immune system in the fight against diseases such as cancer.This talk was given at the Gladstone-UCSF Institute of Genomic Immunology Symposium on November 3, 2021.